The Member Magazine of the American Society for Biochemistry and Molecular Biology

Total Page:16

File Type:pdf, Size:1020Kb

The Member Magazine of the American Society for Biochemistry and Molecular Biology Vol. 14 / No. 3 / March 2015 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY CONTENTS NEWS FEATURES PERSPECTIVES 2 14 50 PRESIDENT’S MESSAGE GIVING PARASITES THEIR DUE COORDINATES Conscience of commitment Chasing the North American Dream 20 4 STEAM 52 NEWS FROM THE HILL When our DNA is fair game CAREER INSIGHTS Gene-editing summit A Q&A with Clemencia Rojas 22 5 ANNUAL MEETING POINTERS 14 MEMBER UPDATE 32 8 ANNUAL AWARDS RETROSPECTIVE Marion Sewer (1972 – 2016) 22 10 JOURNAL NEWS 10 Turning on the thyroid 20 11 Using microRNAs to target cancer cells 12 A mouse model for Hajdu–Cheney syndrome 13 One gene, two proteins, one complex 8 32 50 2016 10 Annual Aards MARCH 2016 ASBMB TODAY 1 PRESIDENT’S MESSAGE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY Conscience OFFICERS COUNCIL MEMBERS Steven McKnight Squire J. Booker of commitment President Karen G. Fleming Gregory Gatto Jr. Natalie Ahn Rachel Green By Steven McKnight President-Elect Susan Marqusee Karen Allen Jared Rutter Secretary Brenda Schulman Michael Summers very four years, my institution work with the American Society for Toni Antalis Treasurer requires that I take a course Biochemistry and Molecular Biol- ASBMB TODAY EDITORIAL ADVISORY BOARD E and exam regarding conicts ogy, I can help organize and attend EX-OFFICIO MEMBERS Charles Brenner of interest. Past courses have focused meetings, I can give lectures at other Squire Booker Chair primarily on nancial conicts of institutions, I can help found biotech- Wei Yang Michael Bradley Co-chairs, 2016 Annual Floyd “Ski” Chilton interest, but the course and test I took nology companies, and on and on — Meeting Program Cristy Gelling this past month had a new category so long as the activities have legitimate Committee Peter J. Kennelly on conicts of commitment. e gist relationships to my job as a scientist. Peter J. Kennelly Rajini Rao of things was simple and reasonable: On the home front, my job respon- Chair, Education and Yolanda Sanchez Professional Development Shiladitya Sengupta If I agree to spend a percentage of my sibilities as an employee of UTSWMC Committee Carol Shoulders time on any endeavor or project, it is are varied. For the past two decades, I Daniel Raben imperative that I do so. have been chairman of our biochem- Chair, Meetings Committee ASBMB TODAY My school, the University of Texas istry department, which takes 20 to Angela Hopp Takita Felder Sumter Executive Editor, Southwestern Medical Center at Dal- 30 percent of my time. I also need Chair, Minority Aairs [email protected] Committee las, allows me to spend 20 percent of to perform as a teacher and mentor Lauren Dockett my time on outside activities. Using to my trainees and the young faculty omas Baldwin Managing Editor, Chair, Outreach Committee [email protected] this time, I can engage in any of a members within our department. Wes Sundquist Rajendrani Mukhopadhyay number of activities relating to my Finally, I need to write grant applica- Chair, Public Aairs Chief Science Correspondent, role as a scientist. I can go to speak tions to secure external funding for Advisory Committee [email protected] at high school science fairs, I can my research and manuscripts account- Blake Hill Valery Masterson Chair, Publications Designer, Committee [email protected] Ciarán Finn Correction F. Peter Guengerich Web Editor, Interim editor-in-chief, JBC [email protected] In a feature story on the Human Placenta Project in ASBMB Today’s Herbert Tabor Allison Frick February issue, a researcher photographed working with a placenta was Co-editor, JBC Media Specialist, [email protected] incorrectly identied as David Weinberg. A. L. Burlingame Editor, MCP Barbara Gordon Executive Director, Edward A. Dennis [email protected] William L. Smith Co-editors, JLR Upcoming ASBMB events and deadlines Mar. 15: Accreditation deadline For information on advertising, contact Pharmaceutical Media Inc. at 212-904-0374 or [email protected]. MAR.APR. Apr. 2 – 6: ASBMB annual meeting Apr. 28: ASBMB Hill Day, Washington, D.C. www.asbmb.org/asbmbtoday PRINT ISSN 2372-0409 Articles published in ASBMB Today reect solely the authors’ views and not the ocial positions of the American Society for Biochemistry and Molecular Biology or the institutions with which the authors are aliated. Mentions of products or services are not endorsements. ©2015 ASBMB 2 ASBMB TODAY MARCH 2016 ing for the science that we perform in I strongly doubt that I could function United States, starting around 50 years my lab. as an eective mentor if my time with ago? Back then we were dierent from Among these varied activities, I trainees were cut so drastically. the then-dominant scientic structures am able to spend about half of my What amount of time do I owe to of other countries. Instead of having time directly running my laboratory. my trainees? Does this weigh on my large, hierarchical laboratories directed If I count a 40-hour work week and conscience? Does anyone even look at by distinguished professors, the devote eight hours (20 percent) to this? I can assure you that this issue is United States sprinkled grant funding outside activities, this leaves me 16 not addressed in the classes on conict liberally to much younger scientists hours to run my lab. It is these 16 of interest that I am periodically asked running small laboratories. Our style hours where the rubber meets the to take at my home institution. When let young people drive the car from road with respect to my duties as a I apply for a National Institutes of the very get-go of their independent mentor to the postdoctoral fellows and Health grant, does anyone care how careers. Young scientists did not have graduate students working under my much time I spend mentoring my to pay decades of dues to run their direction. trainees? ese are complicated and own science, waiting as lieutenants On average, over the past two thorny questions. I have thought until they might assume the top role decades, I’ve directed a lab composed about them a lot but never in the of professor. of around ve or six trainees. e context of a conict-of-interest per- ough I have no data to bolster formula I’ve run with equates to being spective. this thesis, I think funding a diverse able to devote around two to three As pointed out above, there is no distribution of young, independent hours per week per trainee. Many question that dierent scientists are scientists was incredibly healthy — people run successful laboratories with more or less ecient with respect to and a big reason why American sci- upwards of double or even quadruple managerial talent. Large laboratories ence has been so successful. I likewise this number of trainees. I’ve found my can operate eectively via a lieuten- do not know how things have evolved. sweet spot; others can function eec- ant system, wherein trainees are not I oer the caution, however, that — as tively with larger laboratory groups. directly mentored by the principal we have enjoyed our own dominance If my three hours a week per investigator of the lab but instead of late — we may have reverted to the trainee were cut to an hour, owing to by intermediaries. Likewise, ineec- hierarchal, professorial system that a larger lab group, I believe I could tive mentors may fail even if aorded we displaced decades ago. Might it be handle this — but not optimally, at unlimited time for trainee interac- proper to begin to pay some level of least for me. Other scientists are more tions. It is clear that strict formulas attention to this question of con- skilled and ecient managers, so I can for mentor-to-trainee balance would science of commitment? understand lab groups consisting of be a terrible idea. On the other hand, even 15 to 20 trainees. What would is it proper that little or no attention Steven McKnight (steven. [email protected]) happen, however, were I to have 50 is paid to the obligation of a scientist is president of the American trainees instead of ve? Instead of to spend an adequate amount of time Society for Biochemistry and getting three hours of mentoring per mentoring his or her trainees? Molecular Biology and chairman week, each trainee would be getting To what can we attribute the suc- of the biochemistry department at the University only 20 minutes per week on average. cess of the biomedical enterprise in the of Texas-Southwestern Medical Center at Dallas. MARCH 2016 ASBMB TODAY 3 NEWS FROM THE HILL Gene-editing summit By Sarah K. Martin ene-editing technology vaulted the three-day summit, the event’s about the appropriateness of the into the public consciousness organizers addressed human gene proposed application.” e commit- G with Science magazine naming editing in three separate categories: tee stopped short of issuing a ban on the CRISPR–Cas gene-editing tool its basic research, somatic clinical use and germline gene editing but reiterated 2015 Breakthrough of the Year. germline clinical use. that human gene-edited cells should CRISPR–Cas is a programmable ey called for exhaustive basic not be used to establish a pregnancy nuclease-enzyme system that allows research on gene editing in human until extensive basic research is done. scientists to edit specic sequences cells to determine potential benets e committee also called for an of DNA, potentially resulting in and risks of clinical use. ey said ongoing discussion of human gene profound changes to an organism. that such research will enhance our editing so that more nations and Importantly, the CRISPR–Cas tech- fundamental scientic understanding diverse stakeholders can participate in nology is specic, accurate and easily of the biology of human embryos and the conversation.
Recommended publications
  • Table of Contents (PDF)
    January 12, 2016 u vol. 113 u no. 2 From the Cover E249 Drought impacts on California forests E172 Kinases and prostate cancer metastasis E229 Potassium channel and sour taste 262 Tuning protein reduction potential 380 Lipid target of autoreactive T cells Contents THIS WEEK IN PNAS Cover image: Pictured is a 3D image of 237 In This Issue the canopy water content (CWC) of trees in the Jasper Ridge Biological Preserve at Stanford University, with low and high LETTERS (ONLINE ONLY) water content shown in red and blue, respectively. Gregory P. Asner et al. E105 Is nitric oxide important for the diastolic phase of the lymphatic found that CWC decreased measurably contraction/relaxation cycle? for an estimated 10.6 million hectares of Michael J. Davis forest, containing up to 888 million large E106 Reply to Davis: Nitric oxide regulates lymphatic contractions trees, between 2011 and 2015, with 1 Christian Kunert, James W. Baish, Shan Liao, Timothy P. Padera, and Lance L. Munn million hectares experiencing greater E107 Lion populations may be declining in Africa but not as Bauer et al. suggest than 30% CWC loss. The results suggest Jason Riggio, Tim Caro, Luke Dollar, Sarah M. Durant, Andrew P. Jacobson, Christian Kiffner, that if drought conditions in California Stuart L. Pimm, and Rudi J. van Aarde continue, forests might undergo E109 Reply to Riggio et al.: Ongoing lion declines across most of Africa warrant substantial changes. See the article by urgent action Asner et al. on pages E249–E255. Image Hans Bauer, Guillaume Chapron, Kristin Nowell, Philipp Henschel, Paul Funston, Luke T.
    [Show full text]
  • A Matter of Degree We Ask Experts What Steers So Many Black Scientists Toward Earning a Master’S Before a Ph.D
    Vol. 19 / No. 2 / February 2020 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY A matter of degree We ask experts what steers so many black scientists toward earning a master’s before a Ph.D. Don’t wait a lifetime for a decision. C. elegans daf-2 mutants can live up to 40 days. JBC takes only 17 days on average to reach a fi rst decision about your paper. Learn more about fast, rigorous review at jbc.org. www.jbc.org NEWS FEATURES PERSPECTIVES 2 24 52 EDITOR’S NOTE A MATTER OF DEGREE A BEGINNER’S GUIDE TO MINORITY Picking up the slack What steers so many black scientists toward PROFESSOR HIRES 3 earning a master’s before a Ph.D.? NEWS FROM THE HILL 34 Acting to protect research integrity MEYERHOFF SCHOLARS A model for increasing diversity in STEM ANNUAL 4 MEETING MEMBER UPDATE 36 INCLUSIVE EXCELLENCE 7 36 A goal of lasting change NEWS 39 Program at Northeastern aims to fix the Honoring undergrads who promote diversity institution 8 40 RETROSPECTIVE FOR VULNERABLE POPULATIONS, Kensal E. van Holde (1928 – 2019) THE THORNY ETHICS OF GENETIC DATA COLLECTION 10 44 RESEARCH SPOTLIGHT JBC/TABOR AWARDS Understanding how arsenic changes 44 chromatin and causes cancer Award winners to speak at annual 13 24 meeting 45 NEWS Lavrsen finds endless possibilities Don’t wait a lifetime for a decision. Nan-Shan Chang has made WWOX in PTMs his life’s work 46 Varghese roams from forests to C. elegans daf-2 mutants can live up to 40 days.
    [Show full text]
  • Biochemistrystanford00kornrich.Pdf
    University of California Berkeley Regional Oral History Office University of California The Bancroft Library Berkeley, California Program in the History of the Biosciences and Biotechnology Arthur Kornberg, M.D. BIOCHEMISTRY AT STANFORD, BIOTECHNOLOGY AT DNAX With an Introduction by Joshua Lederberg Interviews Conducted by Sally Smith Hughes, Ph.D. in 1997 Copyright 1998 by The Regents of the University of California Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the Nation. Oral history is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well- informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is indexed, bound with photographs and illustrative materials, and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ************************************ All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and Arthur Kornberg, M.D., dated June 18, 1997. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley.
    [Show full text]
  • Medical Center
    VanderbiltUniversityMedicalCenter Medical Center School of Medicine School of Nursing Hospital and Clinic Vanderbilt University 2002/2003 Containing general information and courses of study for the 2002/2003 session corrected to 1 July 2002 Nashville The University reserves the right, through its established procedures, to modify the require- ments for admission and graduation and to change other rules, regulations, and provisions, including those stated in this bulletin and other publications, and to refuse admission to any student, or to require the withdrawal of a student if it is determined to be in the interest of the student or the University. All students, full- or part-time, who are enrolled in Vanderbilt courses are subject to the same policies. Policies concerning non-curricular matters and concerning withdrawal for medical or emo- tional reasons can be found in the Student Handbook. EQUAL OPPORTUNITY In compliance with federal law, including the provisions of Title IX of the Education Amend- ments of 1972, Sections 503 and 504 of the Rehabilitation Act of 1973, and the Americans with Disabilities Act of 1990, Vanderbilt University does not discriminate on the basis of race, sex, religion, color, national or ethnic origin, age, disability, or military service in its administration of educational policies, programs, or activities; its admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. In addition, the University does not discriminate on the basis of sexual orien- tation consistent with University non-discrimination policy. Inquiries or complaints should be directed to the Opportunity Development Officer, Baker Building, VU Station B #351809 Nashville, Tennessee 37235-1809.
    [Show full text]
  • 2012 Annual Report
    Memorial Sloan-Kettering Cancer Center 2012 ANNUAL REPORT A SHARED VISION A SINGULAR MISSION Nurse practitioner Naomi Cazeau, of the Adult Bone Marrow Transplant Service. PING CHI PHYSICIAN-SCIENTIST 10 STEPHEN SOLOMON ALEXANDER RUDENSKY INTERVENTIONAL IMMUNOLOGIST RADIOLOGIST 16 12 VIVIANE TABAR The clinicians and scientists of NEUROSURGEON Memorial Sloan-Kettering share a vision and 18 a singular mission — to conquer cancer. STEPHEN LONG STRUCTURAL BIOLOGIST They are experts united against a 20 SIMON POWELL complex disease. Each type of cancer R ADIATION ONCOLOGIST 24 ETHEL LAW is different, each tumor is unique. Set free NURSE PRACTITIONER in surroundings that invite the sharing of 26 ideas and resources, they attack the CHRISTINA LESLIE complexity of cancer from every angle COMPUTATIONAL BIOLOGIST and every discipline. 34 SCOTT ARMSTRONG PEDIATRIC ONCOLOGIST 30 TO JORGE REIS-FILHO EXPERIMENTAL PATHOLOGIST CONQUER 38 CANCER 04 Letter from the Chairman and the President A complete version of this report — 42 Statistical Profile which includes lists of our donors, 44 Financial Summary doctors, and scientists — 46 Boards of Overseers and Managers is available on our website at 49 The Campaign for Memorial Sloan-Kettering www.mskcc.org/annualreport. 4 5 Letter from the Chairman In 2012 the leadership of Memorial Sloan-Kettering endorsed Douglas A. Warner III These programmatic investments require leadership and and the President a $2.2 billion investment in a clinical expansion that will set vision. Our new Physician-in-Chief, José Baselga, joined the stage for a changing care paradigm into the next decade us on January 1, 2013. An internationally recognized and beyond.
    [Show full text]
  • Table of Contents (PDF)
    September 6, 2011 u vol. 108 u no. 36 u 14707–15010 Cover image: Pictured are gastric epithelial cells infected with the gut bacteria, Helicobacter pylori, which are associated with an increased risk of gastric cancers. Isabella M. Toller et al. found that H. pylori infection damages the genome of host cells, causing breaks in both complementary strands of DNA. The damage triggered DNA repair responses, but pro- longed infection resulted in unrepaired DNA breaks and harmed host cell viability. The findings suggest a possible mechanism for the bacteria’s carcinogenic properties. See the article by Toller et al. on pages 14944–14949. Image courtesy of Martin Oeggerli (Micronaut and School of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland). From the Cover 14944 Helicobacter pylori can cause DNA damage 14723 MicroRNA and olfactory conditioning 14819 Unraveling protein–DNA interactions 14902 Pathogenesis of Epstein-Barr virus 14998 Neuronal basis of delayed gratification 14711 Olfactory habituation: Fresh insights from flies Contents David L. Glanzman See companion articles on pages E646 and 14721 and pages E655 and 14723 THIS WEEK IN PNAS 14713 (Compressed) sensing and sensibility Vijay S. Pande See companion article on page 14819 14707 In This Issue 14715 Transcription factor RBPJ/CSL: A genome-wide look at transcriptional regulation Lucio Miele LETTERS (ONLINE ONLY) See companion articles on pages 14902 and 14908 E625 Social influence benefits the wisdom of individuals in the crowd Simon Farrell PNAS PLUS (AUTHOR SUMMARIES) E626 Reply to Farrell: Improved individual estimation success can imply collective tunnel vision BIOLOGICAL SCIENCES Heiko Rauhut, Jan Lorenz, Frank Schweitzer, and Dirk Helbing BIOCHEMISTRY 14717 Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner COMMENTARIES Hua-Lin Zhou, Melissa N.
    [Show full text]
  • Aziz SANCAR WINS Nobel Prize
    Advancing SCIENCE Aziz Sancar, 2015 Nobel laureate in chemistry extremely proud that he is a member of TWAS, and we offer him heartfelt congratulations.” Sharing the prize with Sancar are two other chemists who have made pioneering discoveries in gene repair: Swedish native Tomas Lindahl of the Francis Crick Institute and Clare Hall Laboratory in Hertfordshire, UK, and American Paul Modrich of the Howard Hughes Medical Institute and Duke University School of Medicine in North Carolina. “Systematic work” by the three researchers “has made a decisive contribution to the understanding of how the living cell functions, as well as providing knowledge about the AZIZ SANCAR molecular causes of several hereditary diseases and about mechanisms behind both cancer development and WINS NOBEL PRIZE aging,” the Royal Swedish Academy of Sciences said in announcing the prizes. by Edward W. Lempinen Sancar, 69, was born in Savur, a small town in southeastern Turkey. The Turkish-born DNA to remove the damaged genetic He was the seventh of eight children. code. His initial discoveries at Yale “My parents were both illiterate,” he scientist, elected to TWAS University in the United States focused said in a 2005 profile published in the in 1994, shares the 2015 on E. coli bacteria; more recently, at Proceedings of the National Academy the University of North Carolina in the of Sciences (USA), “but they valued the Nobel Prize in chemistry United States, he detailed the workings importance of education and did their of this DNA repair in humans. best to ensure that all of their children for research into DNA Sancar is the first native of Turkey to would receive some education.” repair.
    [Show full text]
  • Suzanne Pfeffer
    July 2010 ASBMB PreSidentiAl PriMer: Suzanne Pfeffer American Society for Biochemistry and Molecular Biology AAdjuvdjuvAAntnt IImmunothermmunotherAApypy ususIIngng KKrnrn70007000 KRN7000 (α-Galactosyl Ceramide) Avanti Number 867000 Supplier: Funakoshi Co. Ltd. Hepatic metastasis is a major clinical problem in cancer treatment. We examined antitumor ac- tivity of alpha-galactosylceramide (KRN7000) on mice with spontaneous liver metastases of re- ticulum cell sarcoma M5076 tumor cells (spontaneous metastasis model). In this model, all mice that were s.c. challenged with one million tumor cells developed a solid s.c. mass by day 7 and died of hepatic metastases. In the current study, we administered 100 microg/kg of KRN7000 to the model mice on days 7, 11, and 15. This treatment suppressed the growth of established liver metastases and resulted in the prolongation of survival time. Fluorescence-activated cell sorter analysis of phenotypes of spleen cells, hepatic lymphocytes, and regional lymph node cells around the s.c. tumor revealed that CD3+NK1.1+ (NKT) cells increased in hepatic lym- phocytes of the KRN7000-treated mice. Cytotoxic activity and IFN-gamma production of hepatic lymphocytes were augmented in comparison with those of spleen cells and regional LN cells. At the same time, interleukin (IL)-12 production of hepatic lymphocytes was markedly enhanced. Neutralization of IL-12 using a blocking monoclonal antibody diminished the prolonged survival time. These results showed that the in vivo antitumor effects of KRN7000 on spontaneous liver metastases were dependent on the endogenous IL-12 production, where NKT cells in the liver are suggested to be involved. Adjuvant immunotherapy using KRN7000 could be a promising modality for the prevention of postoperative liver metastases.
    [Show full text]
  • Nfap Policy Brief » October 2019
    NATIONAL FOUNDATION FOR AMERICAN POLICY NFAP POLICY BRIEF» OCTOBER 2019 IMMIGRANTS AND NOBEL PRIZES : 1901- 2019 EXECUTIVE SUMMARY Immigrants have been awarded 38%, or 36 of 95, of the Nobel Prizes won by Americans in Chemistry, Medicine and Physics since 2000.1 In 2019, the U.S. winner of the Nobel Prize in Physics (James Peebles) and one of the two American winners of the Nobel Prize in Chemistry (M. Stanley Whittingham) were immigrants to the United States. This showing by immigrants in 2019 is consistent with recent history and illustrates the contributions of immigrants to America. In 2018, Gérard Mourou, an immigrant from France, won the Nobel Prize in Physics. In 2017, the sole American winner of the Nobel Prize in Chemistry was an immigrant, Joachim Frank, a Columbia University professor born in Germany. Immigrant Rainer Weiss, who was born in Germany and came to the United States as a teenager, was awarded the 2017 Nobel Prize in Physics, sharing it with two other Americans, Kip S. Thorne and Barry C. Barish. In 2016, all 6 American winners of the Nobel Prize in economics and scientific fields were immigrants. Table 1 U.S. Nobel Prize Winners in Chemistry, Medicine and Physics: 2000-2019 Category Immigrant Native-Born Percentage of Immigrant Winners Physics 14 19 42% Chemistry 12 21 36% Medicine 10 19 35% TOTAL 36 59 38% Source: National Foundation for American Policy, Royal Swedish Academy of Sciences, George Mason University Institute for Immigration Research. Between 1901 and 2019, immigrants have been awarded 35%, or 105 of 302, of the Nobel Prizes won by Americans in Chemistry, Medicine and Physics.
    [Show full text]
  • El Premio Nobel Alrededor Del ADN Nobel Prizes About DNA Recibido: Febrero 15 De 2016 | Revisado: Marzo 17 De 2016 | Aceptado: Mayo 12 De 2016
    El premio nobel alrededor del ADN Nobel prizes about DNA Recibido: febrero 15 de 2016 | Revisado: marzo 17 de 2016 | Aceptado: mayo 12 de 2016 1,2 DULCE DELGADIllO-ÁLVAREZ ABSTRACT The Nobel Prize is an international award given annually to individuals or institutions that have made investigations, discoveries or contributions to humanity in the immediate previous year or du- ring the course of their life. The awards were ins- tituted in 1895 as the last will of swedish chemist Alfred Nobel and began to be distributed in 1901. Two of the specialties in which the prize is awar- ded are Chemistry and Physiology or Medicine. The purpose of this brief review is to count those researchers who have earned this award in the dis- ciplines mentioned from 114 years ago and who- se work has orbited around the deoxyribonucleic acid or DNA. We mention studies on its discovery, structure and molecular characterization of this and of the other molecules that in coordination with it turn it into the molecule responsible for storing and transmitting genetic information of all organisms that inhabit our planet. Key words: Nobel Prize, deoxyribonucleic acid, discovery, structure, molecular biology RESUMEN El Premio Nobel es un galardón internacional otorgado cada año a personas o instituciones que hayan realizado investigaciones, descubrimientos o contribuciones a la humanidad en el año inme- diato anterior o en el transcurso de su vida. Los premios se instituyeron en 1895 como última vo- luntad del químico sueco Alfred Nobel y comenza- ron a entregarse en 1901. Dos de las especialidades en las que el Premio es otorgado son en Quími- ca y en Fisiología o Medicina.
    [Show full text]
  • Talking with Nobel Laureate Robert J. Lefkowitz, MD
    MEET THE 2021 ENDOCRINE SOCIETY LAUREATE AWARD WINNERS APRIL 2021 THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS INTERNATIONAL The Accidental SCIENTIST Talking with Nobel Laureate Robert J. Lefkowitz, MD When Robert J. Lefkowitz, MD, received the Nobel Prize for Chemistry in 2012, that was only part of his storied career as a physician scientist. A self-proclaimed “accidental scientist,” Lefkowitz talks to Endocrine News about his recently published autobiography, misconceptions about scientists, how it felt to win the Nobel, and much more! ON THE MOVE: Joy Wu, MD, PhD, relocates her lab during a pandemic. STAR POWER: Rounding up the Rising Stars Power Talks winners CLINICAL PRACTICE GUIDELINES FROM THE ENDOCRINE SOCIETY THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS 2020 – 2022 EDITORIAL ADVISORY BOARD Henry Anhalt, DO Bergen County Pediatric Endocrinology Sally Camper, PhD Department of Human Genetics University of Michigan Medical School Rodolfo J. Galindo, MD Assistant Professor of Medicine Mount Sinai School of Medicine Christian M. Girgis, MBBS, PhD, FRACP Royal North Shore and Westmead Hospitals University of Sydney, Australia Lipid Management Andrea Gore, PhD Division of Pharmacology and Toxicology University of Texas in Patients with Daniel A. Gorelick, PhD Endocrine Disorders Baylor University, Houston, Texas M. Carol Greenlee, MD, FACP A NEW STANDARD FOR CARE Western Slope Endocrinology Grand Junction, Colo. (Faculty for Transforming Clinical Practice initiative [TCPi]) Learn the latest best practices Gary D. Hammer, MD, PhD Millie Schembechler Professor of Adrenal Cancer, for assessing and treating high Endocrine Oncology Program cholesterol in patients with endocrine University of Michigan diseases like hypothyroidism, Robert W. Lash, MD Chief Professional & Clinical Officer, Endocrine Society menopause, and Cushing Syndrome.
    [Show full text]
  • Celebrating the Work of Nobel Laureate Paul Modrich
    SCIENCE CHINA Life Sciences • NEWS AND VIEWS • January 2016 Vol.59 No.1: 93–96 doi: 10.1007/s11427-015-4989-y Celebrating the work of Nobel Laureate Paul Modrich Guo-Min Li Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA Received December 8, 2015; accepted December 12, 2015; published online December 17, 2015 Citation: Li, G.M. (2016). Celebrating the work of Nobel Laureate Paul Modrich. Sci China Life Sci 59, 93–96. doi: 10.1007/s11427-015-4989-y On October 7, 2015, the Nobel Prize Committee announced that the 2015 Nobel Prize in Chemistry had been awarded jointly to Professors Paul Modrich, Tomas Lindahl and Aziz Sancar (Figure 1), each of whom made ground-breaking discoveries about the molecular mechanisms of DNA Re- pair. In one of life’s unpredictable turns, Paul was among the last individuals in his entire personal, professional and social network to learn of the Committee’s decision, be- cause Paul was very far “off-the-grid” at the time of the announcement. The news that he had been selected as a 2015 Nobel Laureate may have taken Paul by surprise, but Figure 1 (color online) Paul Modrich, Aziz Sancar and Tomas Lindahl share the 2015 Nobel Prize in Chemistry. The photo was taken at the Nobel it certainly was not a surprise to most, if not all, of Paul’s Award Ceremony on December 10, 2015, when professors Lindahl (left), colleagues, students, family and friends.
    [Show full text]